Trial intelligence / Profile preview

Tranexamic Acid for Reducing Blood Loss in Maxillofacial Trauma Surgery

NCT07392034Phase 2Completed

Sponsor
Nishtar Medical University
Start
Jan 2025
Primary completion
Jun 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of tranexamic acid in Maxillofacial trauma (MFT), sponsored by Nishtar Medical University. Started Jan 2025; status: completed.

02

Drugs

tranexamic acid
03

Conditions

Maxillofacial trauma (MFT)

Beyond the preview

Go deeper on NCT07392034.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07392034.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call